Challenging the Science Publishing Status Quo

WHAT: F1000Research Sets New Standards for Transparency through Open Science Publishing

WHEN: Monday, April 22, 2013 - 5:30pm – 8:30pm

WHERE: Boston Convention Center, Room #052A 415 Summer St, Boston, MA 02210 (Please enter the convention center through either the south parking lot entrance on level zero or the main entrance on level one at the north end of the building.)

WHY: Open Access has liberated journal content from behind publisher pay walls but scientific progress remains constrained by publishing practices that keep peer review and data hidden from view. F1000Research, a new journal from Faculty of 1000, now delivers on the promise of Open Science with fast publication, transparent peer-review, and full data access for all research papers.

This event brings together leading minds in life-sciences to discuss the benefits of Open Science publishing for the research community.

The discussion will cover the significant issues currently affecting the way research findings are published including:

  • The importance of rapid publication and the negative impact of delays;
  • The benefits of completely open and transparent peer review ;
  • The importance of open publication of all data in order to enable reuse and the testing of reproducibility by others;
  • The implications of the move towards open access (and full CC-BY access) by governments and funders;
  • The benefits of publishing small science findings, null/negative/replication results, and other non-standard studies.

WHO: The distinguished list of speakers from the scientific community includes:

Vitek Tracz - Chairman and Founder, F1000, and a pioneering supporter of Open Access

Steven Hyman - Distinguished Service Professor of Stem Cell and Regenerative Biology and Scholar in Residence, Broad Institute, Harvard University and MIT (and past-Provost, Harvard University)

Keith Flaherty - Director of Developmental Therapeutics, Massachusetts Cancer Center

Gary Borisy - Former President and Director, Marine Biological Laboratory, Woods Hole

Lawrence Kane - Director, Immunology Graduate Program, University of Pittsburgh

Sue Griffin - Dillard Professor and Vice Chairman, Donald W. Reynolds Department of Geriatrics, University of Arkansas for Medical Sciences

F1000 will be participating in this year’s Experimental Biology conference. If you are attending the conference but are not able to attend the F1000 event, please visit the company at Booth #534. A company spokesperson will be on hand to address questions about the company and its open access journal, F1000Research.

About F1000Research

Based in the United Kingdom, F1000Research is an original Open Access journal for life-scientists. It offers immediate publication, transparent peer review (post-publication), and full data deposition and sharing, and accepts all scientifically sound articles, including single findings, case reports, protocols, replications, and null/negative results as well as more traditional articles. F1000Research is published by Faculty of 1000 (F1000).

About Faculty of 1000 (F1000)

Faculty of 1000 is the publisher of four unique services that support and inform the work of life scientists and clinicians. F1000Prime and F1000Trials provide a layer of expert opinion and guidance on published articles, and F1000Research and F1000Posters present original research via an Open Access platform that encourages transparency, sharing and debate. Members of F1000’s executive team have helped to create and launch numerous successful online scientific resources, including the world’s first Open Access publisher, BioMed Central.

For Media Inquiries
Kristin Vincenzo / Michelle Suconick
Fusion Public Relations (on behalf of F1000)
[email protected] / [email protected]